Enoxaparin Sodium Prices Trend and Forecast
North America
Enoxaparin
Sodium Prices in North America showed a stable trend during the 4th
quarter of 2022. Enoxaparin Sodium imports were halted during the first week of
October due to China's Golden Week holiday. Given the substantial product
inventories, domestic suppliers were able to meet the demand for the majority
of the quarter, and up until this point, offtakes in the end-user industries
continued to be normal. The unanticipated increase in Covid cases in China
caused a pattern shift in the market for Enoxaparin Sodium at the conclusion of
the quarter. The broken supply chain did, however, gradually heal as the
economy expanded, and there was a major decrease in port backlog in December.
Asia Pacific
In Q4 of 2022, Enoxaparin
Sodium Prices in the Asia Pacific region during the fourth quarter of
2022 were stable. From October to December, FOB Shenzhen prices slightly
decreased in China, going from $24955000 per MT to $24985000 per MT. Due to the
closure of manufacturing facilities for the Golden Week, the first week of
October saw a steady fall in Enoxaparin Sodium orders for China's API market.
It was challenging for the market to catch up to the slight growth seen in some
downstream businesses because Chinese traders had to deal with various
conflicting signals after a one-week break, but strong demand kept the market
afloat. Chinese suppliers and producers were able to meet the entire quarter's
demand thanks to ample supplies there. The administration amended its
zero-Covid rules in response to criticism and significant unrest in the nation
in December, leaving it vulnerable again.
Europe
The market for Enoxaparin Sodium
in the European region matched the trend in North America and showed steady
market sentiments. Due to the unexpected rise in COVID cases, which resulted in
a continuous fall in demand, international demand was higher in the first part
of the quarter than it was in December. Nevertheless, the circumstances in
Russia and Ukraine, as well as COVID-19 cases, all continued to have a negative
effect on the overall market.
ChemAnalyst tackles the primary
difficulty areas of the worldwide chemical, petroleum, pharmaceutical, and
petrochemical industries, empowering decision-makers to make informed
decisions. It examines and analyses geopolitical risks, environmental concerns,
raw material availability, supply chain functioning, and technological
disruption. It focuses on market volatility and guarantees that clients manage
obstacles and hazards effectively and efficiently. ChemAnalyst's primary
expertise has been data timeliness and accuracy, benefiting both local and
global industries by tuning in to real-time data points to execute
multibillion-dollar projects internationally.
Comments
Post a Comment